LBT — LBT Innovations Share Price
Last trade - 00:00- AU$26.45m
- AU$26.50m
- AU$2.15m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10.37 | ||
| Price to Tang. Book | 10.37 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 13.2 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -263.65% | ||
| Return on Equity | -197.95% | ||
| Operating Margin | -904.09% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 2.9 | 1.75 | 1.43 | 2.27 | 2.15 | n/a | n/a | -18.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
LBT Innovations Limited is a medical technology company. The Company is engaged in researching, developing and commercializing technologies for the healthcare and laboratory supply markets and manufacture and sales of the Automated Plate Assessment System (APAS Independence). Its products include APAS Independence, APAS Analysis Modules, APAS-AMR Analysis Module, and APAS PharmaQ. The APAS Independence is a platform technology that automates culture-plate screening and interpretation. The APAS Analysis Modules are the intelligent image analysis software that works together with the APAS Independence to enable the screening of microbiology culture plates. The APAS-AMR Analysis Module uses artificial intelligence mage analysis platform to read and interpret antimicrobial susceptibility tests (ASTs) for the detection of antimicrobial resistance (AMR). The APAS PharmaQC provides automated imaging, analysis and interpretation of microbiology culture plates used in environmental monitoring.
Directors
- Joanne Moss NEC
- Brenton Barnes CEO
- Raymond Ridge CFO
- Peter Bradley VBD
- Simon Arkell NED
- Damian Lismore NED
- Brian O' Dwyer NED
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 19th, 2004
- Public Since
- July 31st, 2006
- No. of Shareholders
- 2,766
- No. of Employees
- 17
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 1,259,676,995
- Address
- 16 Anster Street, ADELAIDE, 5000
- Web
- https://www.lbtinnovations.com/
- Phone
- +61 882271555
- Auditors
- HLB Mann Judd
Latest News for LBT
Upcoming Events for LBT
Full Year 2024 LBT Innovations Ltd Earnings Release
Similar to LBT
Actinogen Medical
Australian Stock Exchange - SEATS
Adalta
Australian Stock Exchange - SEATS
Algorae Pharmaceuticals
Australian Stock Exchange - SEATS
Alterity Therapeutics
Australian Stock Exchange - SEATS
Amplia Therapeutics
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:13 UTC, shares in LBT Innovations are trading at AU$0.02. This share price information is delayed by 15 minutes.
Shares in LBT Innovations last closed at AU$0.02 and the price had moved by -47.5% over the past 365 days. In terms of relative price strength the LBT Innovations share price has underperformed the ASX All Ordinaries Index by -51.1% over the past year.
The overall consensus recommendation for LBT Innovations is Buy. You can view the full broker recommendation list by unlocking its StockReport.
LBT Innovations does not currently pay a dividend.
LBT Innovations does not currently pay a dividend.
LBT Innovations does not currently pay a dividend.
To buy shares in LBT Innovations you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.02, shares in LBT Innovations had a market capitalisation of AU$26.45m.
Here are the trading details for LBT Innovations:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: LBT
Based on an overall assessment of its quality, value and momentum LBT Innovations is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LBT Innovations. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +294.1%.
As of the last closing price of AU$0.02, shares in LBT Innovations were trading +24.42% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The LBT Innovations PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
LBT Innovations' management team is headed by:
- Joanne Moss - NEC
- Brenton Barnes - CEO
- Raymond Ridge - CFO
- Peter Bradley - VBD
- Simon Arkell - NED
- Damian Lismore - NED
- Brian O' Dwyer - NED